IP Library Granted Patent US 7,183,253
Granted Patent B2
US 7,183,253 · App. 10/771,652 · Granted Feb 27, 2007

Substantially pure glycopeptide antibiotics AC-98-1, AC-98-2, AC-98-3, AC-98-4 and AC-98-5

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,183,253
App. No.
10/771,652
Granted
Feb 27, 2007
Kind
B2
Abstract

The invention provides new substantially pure antibiotics designated AC-98-1, AC-98-2, AC-98-3, AC-98-4 and AC-98-5 derived from the microorganism Streptomyces hygroscopicus.

Claims (16)

1. A substantially pure compound having the structure

or pharmaceutically acceptable salts, thereof.

2. A substantially pure compound according to claim 1 and having the structure

3. A method for treating bacterial infections in warm blooded animals which comprises providing to said animals an antibacterially effective amount of a compound according to claim 2 .

4. A pharmaceutical composition which comprises a compound according to claim 2 in association with a pharmaceutically acceptable carrier.

5. A substantially pure compound having the structure

or pharmaceutically acceptable salts thereof.

6. A substantially pure compound according to claim 5 having the structure

7. A method for treating bacterial infections in warm blooded animals which comprises providing to said animals an antibacterially effective amount of a compound according to claim 6 .

8. A pharmaceutical composition which comprises a compound according to claim 6 in association with a pharmaceutically acceptable carrier.

9. A substantially pure compound having the structure

or pharmaceutically acceptable salts thereof.

10. A substantially pure compound according to claim 9 having the structure

or pharmaceutically acceptable salts thereof.

11. A method for treating bacterial infections in warm blooded animals which comprises providing to said animals an antibacterially effective amount of a compound according to claim 10 .

12. A pharmaceutical composition which comprises a compound according to claim 10 in association with a pharmaceutically acceptable carrier.

Assignments (4)
ASSIGNEE CHANGE OF ADDRESS Recorded May 2, 2017
From: ZOETIS SERVICES LLC
To: ZOETIS SERVICES LLC
Reel/Frame 042382/0613 →
MERGER Recorded May 13, 2015
From: ZOETIS WHC 2 LLC
To: ZOETIS SERVICES LLC
Reel/Frame 035623/0959 →
CHANGE OF NAME Recorded Mar 27, 2013
From: PAH WHC 2 LLC
To: ZOETIS WHC 2 LLC
Reel/Frame 030120/0783 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2013
From: WYETH HOLDINGS CORPORATION
To: PAH WHC 2 LLC
Reel/Frame 030062/0025 →